Analyst Ratings for Cardiff Oncology (CRDF)

CRDF Rating Summary

CRDF Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRDF
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $25.00 (+264.4%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/9/2021 Maxim Group
» Updated 9/9/2021
Naureen Quibria New Coverage Buy
(N/A)
25.00
(20.00)
5.76
(6.86)
19.1% Details
11/30/2020 Cowen Marc Frahm New Coverage Outperform
(N/A)
N/A
(N/A)
21.92
(6.86)
-68.7% Details
Like CRDF Ratings? Also take a look at HEPA, TLSA

CRDF Ratings News